This post has been archived and contains information that may be out of date.
On July 6, the Food and Drug Administration amended the Emergency Use Authorization (EUA) for Paxlovid, an orally administered COVID-19 therapeutic drug. The amended EUA expressly permits licensed pharmacists to independently order Paxlovid for individual patients under certain conditions.
This content is restricted to members.
